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CDK5 is an important kinase in nervous system func-
tion, controlling neural development and postsyn-
aptic signal integration. Here we show that CDK5
plays a major role in controlling neurotransmitter
release. Inhibition of CDK5 activity, by either acute
or genetic means, leads to profound potentiation of
presynaptic function, including unmasking of previ-
ously ‘‘silent’’ synapses. Removal of CDK5 activity
additionally unlocks access to the resting synaptic
vesicle pool, which normally remains recalcitrant to
exocytosis and recycling even following prolonged
action potential stimuli. Presynaptic CDK5 levels
are additionally severely depleted by chronic neu-
ronal silencing, a treatment that is functionally similar
to CDK5 knockdown with regard to presynaptic
potentiation. Thus CDK5 appears to be an integral
element in presynaptic homeostatic scaling, and
the resting vesicle pool appears to provide a potent
functional presynaptic homeostatic control param-
eter. These studies thus pinpoint CDK5 as a major
control point for modulation of neurotransmitter
release in mammalian neurons.
INTRODUCTION
Cyclin-dependent kinase 5 (CDK5), a proline-directed serine/
threonine kinase, has emerged in the last decade as an impor-
tant enzyme critical for neural development (Kwon and Tsai,
2000; Ou et al., 2010), neural signaling pathways, and neurogen-
esis (Lagace et al., 2008). In the basal ganglia, CDK5 serves as
a regulator of DARP32, a central control point in dopamine
signaling (Chergui et al., 2004). CDK5 has been implicated in
certain forms of synaptic plasticity, such as hippocampal-
dependent spatial learning (Hawasli et al., 2007) and learned
fear extinction (Sananbenesi et al., 2007). Additionally, CDK5
has become a potential therapeutic target (Wei and Tomizawa,
2007), because it has been implicated in a number of patholog-
ical conditions, including Alzheimer’s disease (Cruz and Tsai,
2004). A number of presynaptic proteins have been identified
as CDK5 substrates (Cousin and Robinson, 2001; Samuels
et al., 2007; Taniguchi et al., 2007), and in nerve terminals this
enzyme has been largely attributed to playing a role in synapticvesicle endocytosis (Anggono et al., 2006; Tan et al., 2003; Tomi-
zawa et al., 2003). Although acute application of a small molecule
inhibitor of CDK5 was previously shown to significantly enhance
synaptic transmission in hippocampus (Tomizawa et al., 2002), it
has been suggested that this results from off-target effects of
this drug via interaction with Ca2+ channels (Yan et al., 2002).
This conclusion relied on the fact that small molecule inhibitors
potentiated calcium currents equally well in the absence of
p35, a major cyclin for CDK5 in the brain; however, residual
activity driven by p39, a synaptically localized CDK5 cyclin
(Humbert et al., 2000), had not been ruled out.
In order to investigate the potential role of CDK5 in neurotrans-
mitter release, we used optical assays of exocytosis that unam-
biguously report measures of presynaptic function without
hindrances arising from potential postsynaptic effects. We took
advantage of both acute pharmacological inhibition of CDK5
and shRNA-meditated ablation of CDK5 activity in combination
with these optical assays. Our experiments revealed that CDK5
normally serves to potently inhibit neurotransmitter release,
which, at the extreme, results in complete silencing of nerve
terminals. Acute inhibition of CDK5 unmasks these previously
inactive presynaptic sites. In active terminals we found that
CDK5 controls access to the ‘‘resting’’ synaptic vesicle pool.
At nerve terminals synaptic vesicles recycle to sustain neuro-
transmitter release during repetitive action potential (AP) firing.
The size of the pool of vesicles that recycles and the kinetics of
each of the recycling steps all play important roles in determining
the efficacy of synaptic function during repetitive stimulation
(Ferna´ndez-Alfonso and Ryan, 2006). We and others have previ-
ously shown that in addition to vesicles that undergo exocytosis
and recycling in response to stimulation (the readily-releasable
and reserve pools), a large fraction of vesicles fail to participate
in recycling, and the size of this fraction varies from synapse
to synapse (Fernandez-Alfonso and Ryan, 2008; Fredj and
Burrone, 2009; Harata et al., 2001; Li et al., 2005). Our experi-
ments show that the size of this resting vesicle pool is deter-
mined by the balance of calcineurin (CN) and CDK5 activity,
and that resting vesicles can be converted to recycling vesicles
through CDK5 inhibition. Furthermore the size of the resting
vesicle pool can be increased by removal of CN. Finally we
show that the endogenous balance of CDK5 and CN activities
is determined by the history of chronic activity, because long
term neuronal silencing by tetrodotoxin (TTX) phenocopies
both acute and shRNA-mediated removal of CDK5 activity with
respect to changes in presynaptic function. We show that that
neuronal silencing leads to a loss of presynaptic CDK5, indi-
cating that this enzyme is a substrate in homeostatic plasticityNeuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc. 797
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aptic control parameter in homeostatic scaling. These studies
thus identify CDK5 as an important control point in determining
neurotransmitter release properties.
RESULTS
In order to measure exocytosis with high fidelity, wemade use of
vGlut1-pHluorin (vG-pH) or vGlut1-pHluorin-mCherry (vG-pH-
mCh) expressed in dissociated hippocampal neurons. pHluorin,
a modified form of GFP whose fluorescence is quenched upon
protonation (pKa 7.1) (Sankaranarayanan et al., 2000), can be
targeted to the lumen of synaptic vesicles by attachment to
one of several different synaptic vesicle proteins. Fusion of
pHluorin into one of the intralumenal loops of the vesicular
glutamate transporter (vGlut1) (Voglmaier et al., 2006) results in
very low surface expression and provides high sensitivity for
measurement of exocytosis (Balaji and Ryan, 2007). We addi-
tionally fused a copy of mCherry, a pH-insensitive and red-
shifted protein, to the cytosolic C terminus of vG-pH. When
targeted to the synaptic vesicle lumen, pHluorin fluorescence
is quenched, and upon AP stimulation and exocytosis it is
relieved (Figure 1A). Following exocytosis, the signal decays
due to endocytic capture of vG-pH and vesicle reacidification.
Although during the stimulus train the signal in principle reflects
the difference between exocytosis and ongoing endocytosis and
reacidification, we previously showed that during the initial 10 s
of stimulation the signal represents almost purely exocytosis,
because the combined kinetics of endocytosis and reacidifica-
tion are too slow to impact the measurement (Kim and Ryan,
2009b). In order to examine the impact of CDK5 inhibition on
presynaptic function, we used Roscovitine, a small molecule
inhibitor, and shRNA-mediated knockdown (KD) of CDK5.
Double transfection of vG-pH and shRNA targeting of CDK5
resulted in an 92% reduction in CDK5 levels (Figures S1A
and S1C, available online). We monitored vG-pH responses to
100 AP stimuli at 10 Hz across 20–40 boutons of an individual
neuron simultaneously. Signals were normalized at each bouton
to the fluorescence value obtained by rapid alkalization of the
entire labeled vesicle pool using NH4Cl, thus correcting the
signals for possible variation in expression levels. Application
of Roscovitine resulted on average in an 2.5-fold potentiation
of exocytosis of the ensemble response (Figures 1A and 1B),
while control cells treated only with vehicle remained unchanged
(Figure S2). Comparison of the response amplitude distribution
across several hundred boutons from many cells showed that
shRNA-mediated removal of CDK5 activity resulted in very
similar responses to those of wild-type (WT) neurons treated
with Roscovitine (Figures 1C and 1D). Furthermore, treatment
of shRNA-treated neurons with Roscovitine resulted in only
a very small further increase in amplitude to a 100 AP stimulus
(Figures 1A and 1B), and transfection of KD neurons with an
shRNA-insensitive cDNA encoding CDK5 fully restored the
100 AP response to that of WT levels (Figures S5A and S5B).
These data demonstrate that CDK5 normally provides a strong
inhibitory influence on presynaptic function and rule out any
significant CDK5-independent impact of Roscovitine in these
measurements.798 Neuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc.Unmasking Presynaptically Silent Synapses by
Inhibition of CDK5
We noted in our control experiments that a small percentage of
synapses showed no measurable signal during a 100 AP stim-
ulus (Figure 1C). These synapses were identified by the signal
obtained following NH4Cl treatment or by the mCherry channel.
Following Roscovitine treatment, however, these previously
silent nerve terminals showed very robust responses to 100 AP
stimuli (Figures 2A and 2B). We quantified the magnitude of the
unmasking by specifically measuring the impact of Roscovitine
treatment on those synapses whose signal in response to the
first 100 AP stimulus waswithin 1 standard deviation of the base-
line noise in the recording, which represented11%of the entire
distribution of synapses in the histograms in Figure 1C. Following
CDK5 inhibition, a large fraction of these specific synapses
showed 100 AP responses that were now well above the noise
floor (Figure 2). The average response of these synapses grew
from an exocytic response that corresponded to 0.5% of the
entire vesicle pool (<1 vesicle, assuming a synaptic vesicle
pool <200 vesicles) to 8%of the entire pool following Roscovitine
treatment. Following Roscovitine treatment 5% of synapses
remained unresponsive to AP-driven activity, almost identical
to the fraction of synapses that were unresponsive in CDK5 KD
neurons (6.1%). Of the synapses whose responses were initially
within the baseline noise, but subsequently gave responses
above the baseline noise (the 5% of the population that
became ‘‘unmasked’’), the mean response was 14%, close
to the central mode of the entire distribution of potentiated
synapses (Figure 1C).
CDK5 Inhibition Unlocks Access to the Resting Synaptic
Vesicle Pool
Under control conditions we previously showed that on aver-
age no more than 50% of the entire vesicle pool typically
undergoes exocytosis, even after several hundred AP stimuli.
Following Roscovitine treatment we noticed that for individual
boutons the 100 AP stimulus resulted in signals as high as
80%–90% of the entire vesicle pool as judged by the fluores-
cence obtained by direct alkalinization with NH4Cl treatment
(Figure 1E). The fact that a mere 100 AP was now driving indi-
vidual synapses to exocytose virtually all of their synaptic vesicle
pool suggests that CDK5 inhibition might be increasing the size
of the available synaptic vesicle pool, presumably through con-
version of nonrecycling vesicles into recycling vesicles. We
tested this hypothesis in two ways. Following exocytosis syn-
aptic vesicle components are recaptured by endocytosis, and
the regenerated synaptic vesicle is reacidified by a V-type
ATPase. During prolonged stimulation, vG-pH signals represent
the balance of exocytosis, endocytosis, and reacidification;
however, in the presence of a V-ATPase inhibitor, the signal
represents the cumulative amount of exocytosis (Sankaranar-
ayanan and Ryan, 2001). An example of this is illustrated in
Figure 3A. After several hundred AP stimuli the fluorescence rea-
ches a plateau, which arises from the fact that all vesicles that
can fuse with the plasma membrane have done so, and have
become trapped in the alkaline state, because even though
endocytosis persists, no reacidification occurs. Thus the entire
recycling pool of synaptic vesicles becomes alkaline at this
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Figure 1. The Exocytosis Elicited by Brief Action Potential Stimuli (100 AP) Is Potentiated following Removal of CDK5 Activity
(A) Representative ensemble average traces of exocytosis stimulated by 100 AP from control, Roscovitine-treated, and CDK5 KD neurons. Cells were transfected
with vG-pH or vG-pH-mCh with or without shRNA of CDK5. Neurons were stimulated at 10 Hz for 10 s with or without Roscovitine (100 mM for 30 min). Intensities
were normalized to the maximal NH4Cl response.
(B) Mean values of amplitudes of 100 AP (10 Hz) responses in WT or CDK5-depleted neurons in the absence or presence of Roscovitine. WT cells in the absence
of Roscovitine showed 11.5% ± 1% (n = 7 cells, 30–50 synapses per cell) response. In the presence of Roscovitine or following CDK5 removal, the responses
grew to 27.9% ± 4% (Roscovitine+ in WT, n = 7) or 27.3% ± 2% (CDK5 KD, n = 6). The combination of Roscovitine and CDK5 KD grew amplitudes only modestly
above either treatment alone (31.9% ± 3%, n = 6). Light gray dots indicate response of individual cells.
(C and D) The distribution of response amplitudes from single boutons from control and Roscovitine-treated (C) or WT and CDK5 KD (D) neurons.
(E) Scatter plot of the data shown in (C) shows that the 3-fold potentiation occurs across the entire distribution. Measurement from 722 boutons obtained in
seven experiments. Dashed line indicates DFbefore = DFafter.
See also Figures S1A and S1C.
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Figure 2. Acute Inhibition of CDK5 Unmasks Silent Synaptic
Boutons
(A) A portion of vG-pH-mCh-expressing synapses (red image) showing no
measurable response to 100 AP stimuli are unmasked following Roscovitine
treatment. White circle indicates a silent bouton. The pseudocolor images
are the DF images of the 100 AP response before and after Roscovitine treat-
ment. Following Roscovitine treatment all synapses potentiate, and the previ-
ously silent synapse now shows a robust response. Scale bar represents 5 mm.
(B) pHluorin traces of individual boutons that went from silent (left traces) to
responsive following Roscovitine treatment (right traces) normalized to the
maximal NH4Cl response. The top red trace corresponds to white circle bou-
ton in the images in (A).
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800 Neuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc.point. Subsequent application of NH4Cl allows one to determine
if any vesicles remained in the acidic state following this pro-
tocol. Under control conditions these measurements indicate
that on average only 51% of the vesicle pool labeled with
vG-pH can participate in recycling (Figures 3A and 3C), in agree-
ment with previous published results (Fernandez-Alfonso and
Ryan, 2008; Li et al., 2005). When we repeated this protocol on
neurons following acute application of Roscovitine, the size of
the recycling pool grew substantially to 80% (Figures 3B and
3C). This trend persisted across all neurons examined, where
the average recycling pool size following CDK5 inhibition was
81%. Single bouton analysis derived from many neurons also
supported this view (Figures 3D and 3E) and demonstrated
that, following acute inhibition of CDK5, recycling pools at indi-
vidual synapses spanned a much narrower range of values
than in untreated neurons.
We next used a different strategy, based on uptake of an exog-
enous tracer (FM4-64) into recycling vesicles. FM dyes are
a family of amphipathic molecules that are impermeant to the
plasma membrane, fluoresce when bound to membranes, and
can be loaded during vesicle cycling into synaptic vesicles.
Following a 600 AP stimulus at 10 Hz in the presence of FM4-
64, nerve terminals become maximally loaded, and exposure
to the dye during a second round of stimulation leads to only
a small increase in total fluorescence (Figures 4B and 4C,
control) in agreement with previous results (Ryan and Smith,
1995). In contrast, if, prior to the attempt to load additional vesi-
cles in a second round of stimulation, the nerve terminals are
incubated in the presence of Roscovitine, a much larger fluores-
cence load is achieved (Figures 4B and 4C, Roscovitine). In the
continued presence of Roscovitine, these newly loaded vesicles
were fully usable again, because additional stimulation in the
absence of extracellular FM4-64 led to destaining down to levels
that were similar to those of controls. On average the loading
increased by 86% in the presence of Roscovitine compared
with only 11% in controls (Figures 4C and 4D). These data,
combined with the results using vG-pH, demonstrate that acute
inhibition of CDK5 leads to a very large increase in the size of
the recycling vesicle pool by converting resting vesicles into
functional recycling vesicles.
A Balance of CDK5 and CN Activity Determines the Size
of the Recycling and Resting Vesicle Pools
In order to further verify that the increase in pool size was due
to inhibition of CDK5 and not an off-target effect, we used the
vG-pH-based protocol (Figure 3) in CDK5 KD neurons as well
as in neurons transfected with an shRNA targeting the regulatory
subunit of CN (calcineurin B, CNB), one of the main proline-
directed serine/threonine phosphatases known to counteract
CDK5 in nerve terminals (Cousin and Robinson, 2001). The regu-
latory and catalytic subunits of CN form an obligate heterodimer,
and loss of the regulatory subunit leads to complete loss of CN
function (Zeng et al., 2001). Transfection of shRNA-targeting(C) Cumulative distribution of response amplitudes for synapses whose
response was within 1 s of the baseline noise prior to Roscovitine treatment
(red) shifted to responses above the noise (green) after Roscovitine treatment.
See also Figure S2.
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Figure 3. Acute Inhibition of CDK5 Increases the Recycling Pool and Decreases the Resting Pool in Nerve Terminals
(A and B) Representative ensemble averages of traces fromWT and Roscovitine-treated neurons. Cells with or without Roscovitine are stimulated continuously at
10 Hz in the presence of bafilomycin, a proton pump inhibitor. The plateau in fluorescence reflects the complete alkalization of the entire recycling vesicle pool.
Following NH4Cl treatment any remaining acidic vesicles are unmasked, revealing the relative size of the resting vesicle pool. Following Roscovitine treatment the
recycling vesicle pool grows substantially. (Inset top) Corresponding vG-pH images to different parts of the experiment.
(C) Mean values of recycling pool in WT and Roscovitine-treated neurons. (WT = 50.7% ± 3%, n = 7; Roscovitine = 80.8% ± 3%, n = 7). **p < 0.01.
(D and E) Distribution of single bouton recycling pool fractions in WT (D) and Roscovitine-treated (E) neurons.
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CDK5 Control of Presynaptic FunctionCNB resulted in a94% loss of CNB (see Figures S1B and S1C).
We measured the balance of recycling and resting vesicles in
both CDK5 KD and CNB KD neurons and found that, in the
absence of CNB, the recycling fraction was 20% (Figure 5A),
similar to observations made under purely pharmacological
blockade (Kumashiro et al., 2005), and much smaller than in
WT, whereas in the absence of CDK5 it was 79%, almost iden-
tical to the value obtained following acute inhibition. Both
CDK5 and CNB KD phenotypes could be fully rescued by
expression of shRNA-resistant plasmids (Figure S5). Further-
more, acute treatment of CNB KD neurons with Roscovitine
also counterbalanced the loss of CNB, restoring vesicle pool
sizes to near WT levels (Figure S4). The fact that removal of
a phosphatase leads to changes that are opposite to that of
removal of the kinase by either acute or genetic means implies
that it is CDK5’s enzymatic activity that is needed for control of
the recycling and resting synaptic vesicle pool sizes. Single bou-
ton analysis of the recycling fraction also showed that, as withRoscovitine treatment, the range of values exhibited by syn-
apses in either CDK5 KD or CNB KD was much smaller than in
WT, although with CNB removal the values spanned the range
of 0 to 50%.
Chronic Silencing of Neuronal Activity Depletes
Presynaptic CDK5 Activity
In WT neurons the values of the recycling synaptic vesicle pool
fraction showed a large degree of variation from synapse to
synapse (Figure 3D), but following acute inhibition of CDK5,
this range was reduced by roughly half. These data suggest
that the local balance of CN and CDK5 is determined in part at
the individual synapse level and varies from synapse to synapse.
We hypothesized that one potentially important variable across
synapses that might determine this local balance of CN and
CDK5 activity was the chronic local history of activity. We tested
this hypothesis by measuring the recycling synaptic vesicle pool
fraction in neurons that had been silenced for 72 hr using TTX.Neuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc. 801
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Figure 4. Acute CDK5 Inhibition Increases the Size of the Recycling Vesicle Pool as Determined by FM4-64 Uptake
(A) Schematic diagram of FM4-64 dual loading experiment with or without Roscovitine for measurements of recycling pool sizes.
(B and C) Representative ensemble trace of FM4-64 loading and unloading according to protocol with or without Roscovitine. Cells were initially stimulated at
10 Hz for 60 s in the presence of FM4-64 to turn over and label the entire recycling pool. A second round of stimulation in FM4-64 at 10 Hz for 60 s following
incubation in DMSO (control) or Roscovitine was used to determine the impact of acute CDK5 inhibition on engaging the resting vesicle pool. Vesicles labeled
in the two rounds of stimulation were then destained using a third round of 10 Hz 60 s stimulation. Representative images after each loading of FM4-64 in the
absence and in the presence of Roscovitine (inset) are shown. Neurons in control showed only a modest increase in FM staining (11.4% ± 8%); however,
with Roscovitine there was a dramatic increase of FM staining (86.9% ± 2%). **p < 0.01.
(D) First loading of FM4-64 without DMSO or Roscovitine versus second loading of FM4-64 with DMSO or Roscovitine for measurement of an individual bouton
(Control, n = 4111 boutons; Roscovitine, n = 4122 boutons). Dashed line indicates first loading = second loading.
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CDK5 Control of Presynaptic FunctionFigure 6 shows an example of the ensemble response of presyn-
aptic terminals from an individual neuron that had been silenced
in such a fashion prior to the experiment. The size of the recycling802 Neuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc.vesicle pool fraction was significantly larger than in WT (Figures
6A and 6C), similar to CDK5KD neurons. Furthermore, the size of
the recycling pool was identical in CDK5 KD neurons that had
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Figure 5. CDK5 and CN Control the Recycling Pool Size
(A and B) Representative ensemble averages of traces from CDK5 KD and CN KD neurons. Cells cotransfected with vG-pH or vG-pH-mCh and shRNA targeting
CDK5 or CNB were continuously stimulated at 10 Hz in the presence of bafilomycin followed by a NH4Cl challenge. The ratio of the steady-state fluorescence
during stimulation to the NH4Cl maximal value reports the fraction of the total labeled pool that recycles.
(C)Mean values of the recycling pool acrossmany cells showed that the recycling pool is controlled by both CDK5 andCN. (Recycling pool in CDK5 KD= 79.1%±
3%, n = 8; CNB KD = 20.5% ± 3%, n = 13). **p < 0.01.
(D and E) Single bouton recycling pool fractions as a function of the relative NH4Cl signal show that each condition populates only a narrow portion of the range of
values compared with those of WT (Figure 3A).
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CDK5 Control of Presynaptic Functionalso been silenced with TTX (Figures 6B and 6C). Analysis of the
recycling pool values from individual boutons also showed that,
as is the case where CDK5 activity is removed, the available
recycling pool sizes were restricted to a narrower range (inset,
Figures 6A and 6B). The remarkable similarity of chronic neuronal
silencing and explicit ablation of CDK5 activity upon the size of
the recycling vesicle pool strongly suggests that this silencing
directly impacts either presynaptic CDK5 activity levels or the
availability of a relevant CDK5 substrate. In order to examine
this issue, we directly measured protein expression levels with
two different approaches in control compared to chronically
silenced neurons. Western blot analysis of primary neuronal
cell cultures indicated that CDK5 expression decreased to
50% in TTX-treated neuronal cultures compared to control
neuronal cultures, while other presynaptic proteins, including
several known CDK5 substrates, showed no significant change
(Figures 6D and 6E). Given that CDK5 appears to be localizedthroughout the neuron and is also expressed in glial cells
(Figure S1), we surmised that the partial global loss of CDK5
might not accurately reflect presynaptic CDK5 levels. We exam-
ined the impact of chronic silencing on presynaptic CDK5 levels
by direct cotransfection of neurons with GFP-synapsin I and an
epitope-tagged CDK5 (HA-CDK5) that would permit robust
immunocytochemical localization and quantification. These
neurons were then treated with or without TTX for several days
after allowing 4 days for initial protein expression following trans-
fection at DIV 8. Immunocytochemical analysis of GFP-synapsin
I and HA-CDK5 revealed that chronic neuronal silencing leads to
a dramatic suppression of presynaptic CDK5 levels down to
13% of control neurons (Figures 6F and 6G). These data indi-
cate that CDK5 is a substrate of presynaptic homeostatic plas-
ticity and that changes in recycling versus resting pools driven
by silencing can be accounted for by changes in presynaptic
CDK5 levels. As a further test of the hypothesis that TTXNeuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc. 803
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Figure 6. Chronic Suppression by TTX Phenocopies the Loss of CDK5 Activity
(A and B) Representative ensemble average vG-pH traces fromWT or CDK5 KD cells pretreated with TTX. WT or CDK5 KD neurons were treated with TTX (1 mM)
for 72 hr prior to the experiment. Cells cotransfected with vG-pH (WT) or vG-pH and an shRNA targeting CDK5 were continuously stimulated at 10 Hz in the pres-
ence of bafilomycin followed by aNH4Cl challenge. The ratio of the steady-state fluorescence during stimulation to theNH4Clmaximal value reports the fraction of
the total labeled pool that recycles. (Inset) Single bouton recycling pool fractions plotted as a function of the mean relative NH4Cl signal show that each condition
populates only a narrow portion of the range of values compared with those of WT, similar to CDK5 KD (Figure 5C).
(C) Mean values of the recycling pool across many cells showed that the recycling pool is not significantly different betweenWT and CDK5 neurons when they are
pretreated with TTX. (Recycling pool in TTX = 73.9% ± 2%, n = 8; CDK5 KD +TTX = 74.0% ± 3%, n = 5).
(D) Representative bands of western blot. Neuornal cell cultures chronically incubated (TTX+) or not (TTX) were lysed, subjected to SDS-PAGE, transfered to
PVDF membranes, and blotted with antibodies to CDK5 or various presynaptic proteins.
(E) The intensities of blotted band were quantified and used to calculate the ratio of TTX+/TTX. Expression level of CDK5 decreased to 50% while
other presynaptic proteins remained unchanged following chronic exposure to TTX. [CDK5]TTX+/TTX = 51.6% ± 19%, [Dynamin I]TTX+/TTX = 91.6% ± 1%,
[Amphiphysin]TTX+/TTX = 100% ± 1.3%, [Synapsin I]TTX+/TTX = 94.5% ± 4.3%, [VAMP2]TTX+/TTX = 96.1% ± 9.5%, [Tomosyn]TTX+/TTX = 85.5% ± 2.5%,
[Munc18]TTX+/TTX = 99.2% ± 0.2%, [Tubulin]TTX+/TTX = 99.4% ± 2% (n = 4).
Neuron
CDK5 Control of Presynaptic Function
804 Neuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc.
Neuron
CDK5 Control of Presynaptic Functiontreatment impacts the functionality of CDK5, we examined the
impact of TTX treatment on neurons in which CNB activity had
previously been ablated. These experiments revealed that in
the absence of the counterbalancing phosphatase, the recycl-
ing pool sizes returned to those of WT levels in TTX-silenced
neurons (Figure 7A). Finally, we also examined the proportion
of presynaptically silent synapses in TTX-treated neurons. This
analysis showed that the presynaptically silent pool was reduced
to 5.6% of synapses examined, very similar to that of CDK5 KD
(6.1%) and Roscovitine-treated neurons (5%, Figure 2).
The Balance of CDK5 and CN Activities Control
the Kinetics of Exocytosis
In addition to the large increase in the size of the pool of synaptic
vesicles that can engage in exocytosis and recycling, we also
found that the kinetics of exocytosis of that pool depends criti-
cally on the balance of CDK5 and CN activities. The kinetics of
exocytosis can be determined by examining the time course of
the exponential rise in fluorescence of vG-pH during stimulation
in the presence of bafilomycin (Figures 3A, 3B, 5A, 5B, 6A, and
6B). Data from all the different experimental conditions tested
are illustrated in Figure 7B, which shows that all conditions that
resulted in elimination of CDK5 activity and the chronic neuronal
silencing led to exocytosis kinetics that were 2-fold faster than
those seen in WT, whereas in the absence of CN, exocytosis
kinetics slow 3-fold compared with those of WT (Figure 7C).
Similar results were obtained by examining the impact of acute
CDK5 inhibition on the kinetics of FM4-64 destaining (Fig-
ure S6). Our data thus show that exocytosis kinetics, as probed
with repetitive stimulation, is strongly potentiated by loss of
CDK5. Under such stimulus conditions the rate of exocytosis
might be controlled at a variety of different biochemical steps,
including exocytosis and vesicle pool refilling. Examination of
responses to single or paired AP stimuli revealed that removal
of CDK5 had little impact compared to that of controls (Fig-
ure S7). These data suggest that CDK5 is likely acting on a
step upstream of exocytosis in controlling sustained exocytosis
rates and underscore the central claim in this work: that CDK5
normally provides a strong suppression of presynaptic function,
both influencing the number of vesicles that can participate and
the ability to efficiently use those vesicles in driving neurotrans-
mitter release. The experiments also demonstrate that suppres-
sion by CDK5 is counterbalanced by the activity of CN in the
control of exocytosis kinetics.
DISCUSSION
The results we report here demonstrate (1) that the kinase CDK5
normally acts as a strong suppressor of neurotransmitter
release; (2) that it is counterbalanced by the activity of CN; (3)
that the balance of these activities acts both on the kinetics of
exocytosis and in regulating access to the resting synaptic(F) Neurons cotransfected with GFP-synapsin I and HA-CDK5 were fixed and stain
TTX (TTX+) or without (TTX).
(G) The ratios of HA-CDK5 to GFP-synapsin I intensities at individual boutons (
neurons. TTX treatment led to a dramatic suppression of presynaptic HA-C
[HA-CDK5/GFP-Synapsin I]TTX = 100 ± 1.9% [n = 7, 1033 boutons]).vesicle pool; (4) that the functional consequence of the balance
of these two activities in turn is influenced by chronic activity
levels, indicating that these activities are likely potent presyn-
aptic substrates of homeostatic scaling; and (5) that presynaptic
CDK5 levels are highly suppressed by chronic neuronal silenc-
ing, indicating that CDK5 itself is a critical substrate in homeo-
static feedback. Previously, suppression of neurotransmitter
release by the CDK5 inhibitor Roscovitine has been attributed
to direct interaction of the drug with Ca2+ channels, independent
of CDK5 itself. These previous experiments however have not
examined the impact of these inhibitors in the absence of
CDK5, only, in one case, in the absence of one of CDK5’s activa-
tors, the cyclin p35 (Yan et al., 2002). Our results demonstrate
that with respect to the experiments performed here, the action
of Roscovitine is via CDK5, because the removal of CDK5 by
shRNA phenocopies the impact of Roscovitine in each of the
assays performed, the impact of Roscovitine is largely occluded
in the absence of CDK5, and removal of a counterbalancing
phosphatase activity has opposite effects to those of CDK5
inhibition.
Our experiments revealed that a proportion of nerve terminals
(10%) have very little activity in terms of exocytosis, releasing
fewer than 1 vesicle in a 100 AP train at 10 Hz, but approximately
half of these nerve terminals could be shifted to the active state
by acute Roscovitine treatment. Those that did shift showed
very robust responses, well within the central mode of the distri-
bution of all Roscovitine-potentiated synapses. In the absence
of CDK5 or in chronic suppression by TTX, the fraction of inac-
tive synapses was only 5%, similar to the remaining inactive
population in WT after Roscovitine treatment, whereas in the
absence of CN, this population grows significantly (42%).
These data imply that in principle shifting the balance of CDK5
and CN can be used to control the population of presynaptically
silent or presynaptically active synapses, and that a portion of
synapses are normally effectively clamped to an inactive state
by CDK5.
The observation that synaptic terminals contain a fraction of
vesicles in the resting state that do not normally recycle was
first made by carrying out photoconversion of FM-dye-loaded
terminals followed by electron microscopy (EM). These studies
revealed that in spite of maximal dye loading, fewer than one-
third of vesicles appeared to have loaded the dye and therefore
to have undergone recycling (Harata et al., 2001). Subsequent
experiments using pHluorin-tagged synaptic vesicle proteins
came to similar conclusions (Fernandez-Alfonso and Ryan,
2008; Li et al., 2005). We and others hypothesized that such
a reservoir of vesicles could provide an important dynamic vari-
able by which to modify synaptic performance; however, no
known mechanisms for tapping into this pool had been uncov-
ered. For example, previous work demonstrated that increasing
calcium entry (for example by using higher stimulus frequencies)
does not change the size of the accessible vesicle pooled with anti-GFP and anti-HA antibodies after being chronically incubated with
GFP-synapsin-I-positive puncta) were quantified for control and TTX-treated
DK5 ([HA-CDK5/GFP-Synapsin I]TTX+ = 13% ± 1% [n = 9, 947 boutons],
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Figure 7. The Balance of CDK5 and CN Activities Determine Key
Properties of Neurotransmitter Release
(A) Cumulative frequency histograms of single bouton recycling pool size for all
different conditions examined (WT, Roscovitine, CDK5 KD, CN KD, TTX, and
CN TTX).
(B and C) Exocytosis kinetics determined by fitting the vG-pH fluorescence
traces during prolonged stimulation at 10 Hz in the presence of bafilomycin
for each of the conditions examined (WT, CDK5 KD, CN KD, Roscovitine,
TTX, CDK5 KD + Roscovitine, CDK5 KD + TTX, CN KD + Roscovitine, CN
KD + TTX). Traces were fit with a single exponential function to determine
the time constant for exocytosis of the entire recycling pool. The mean values
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that this resting pool provides the source of vesicles for sponta-
neous fusion events and not AP-evoked neurotransmitter
release (Fredj and Burrone, 2009; Sara et al., 2005); however,
this idea has been directly challenged (Groemer and Klingauf,
2007). The studies reported here demonstrate that access to
this resting pool with respect to AP-driven exocytosis is deter-
mined by the balance of CDK5 and CN activities, and that the
consequence of this balance in turn is set by long-term neuronal
activity through control of CDK5 levels. These studies suggest
that dynamic control of this balance could provide a potent
control system for tuning synaptic performance.
Previously, the major role attributed to CDK5 within the nerve
terminal has been that of phosphorylating a number of endocytic
proteins (the dephosphins). One study that examined the impact
of CDK5 inhibition on endocytosis concluded that inhibition of
CDK5 led to an acceleration of endocytosis (Tomizawa et al.,
2003). Our data indicate that the apparent acceleration can be
attributed to the fact that amuch larger pool of vesicles becomes
loaded following CDK5 inhibition. The work we present here has
not examined the impact of CDK5 inhibition on endocytosis
kinetics, which will be the subject of future studies.
A number of studies in the last decade have pointed to the fact
that neuronal circuits appear to be governed by homeostatic
scaling principles, whereby both presynaptic and postsynaptic
efficacy can be autotuned to compensate for long-term changes
in levels of synaptic transmission (Davis, 2006). Significant
evidence has accumulated indicating that postsynaptic scaling
is manifested as a change in glutamate receptor number or com-
position (Turrigiano, 2008). In peripheral synapses, a mechanism
involving Eph receptors, Cdc42, and voltage-gated Ca2+ chan-
nels has been shown to operate during homeostatic regulation
in nerve terminals (Frank et al., 2009). In hippocampal neurons,
chronic silencing of networks in cell culture has been shown to
increase synapse size and presynaptic efficiency (Murthy et al.,
2001; Thiagarajan et al., 2005) and changes in the ratio of two
isoforms of CaMKII (Thiagarajan et al., 2002). The fact that
chronic silencing of neuronal activity decreases expression of
presynaptic CDK5 indicates that this enzyme is an important
element of homeostatic feedback regulation that results in
upregulation of presynaptic function.
Two of the most important tasks for future studies relating to
this work are (1) to identify the substrate or substrates of CDK5
that are controlling access to the resting pool and aremodulating
the kinetics of exocytosis and (2) to determine how CDK5 is nor-
mally regulated at nerve terminals. At present it is unknown if the
acceleration of vesicle pool turnover is a direct consequence of
unlocking the resting vesicle pool or if it results from CDK5/
CN-based modulation of proteins that control a rate-limiting
step in vesicle pool turnover. In addition to the originally identi-
fied set of endocytic proteins (dynamin, amphiphysin, and syn-
aptojanin) collectively referred to as dephosphins, several otherwere as follows: WT = 35.2 ± 2 s, n = 13; CN KD = 92.1 ± 10 s, n = 15; CDK5
KD = 17.7 ± 2 s, n = 17 ; Roscovitine = 18.7 ± 3 s, n = 11; TTX = 19.4 ± 2 s,
n = 10; CDK5 KD + Roscovitine = 14.1 ± 2 s, n = 3; CDK5+ TTX = 17.8 ± 1 s,
n = 4.
See also Figure S6.
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been identified as CDK5 substrates. These include synapsin (Jo-
vanovic et al., 1996;Matsubara et al., 1996), Septin 5 (Amin et al.,
2008), Munc18 (Fletcher et al., 1999; Shuang et al., 1998), CASK
(Samuels et al., 2007), CRIMP (Cole et al., 2008), and the CDK5-
like kinase Pctaire (Cheng et al., 2002; Liu et al., 2006). Although
Roscovitine treatment has been shown to prolong the open
channel lifetime of both P/Q-type and N-type Ca2+ channels,
these measurements were not made in the context of nerve
terminals. Furthermore, the impact on Ca2+ channels had been
attributed to direct interaction with Roscovitine, although these
experiments had not been carried out in the absence of CDK5.
Our studies suggest that at least in the context of the synapse,
Ca2+ channels may be modified in a CDK5-dependent fashion
to control neurotransmitter release properties. Previous work
indicated that for hippocampal neurons the effects of Roscovi-
tine appear to be mediated through P-type Ca2+ channels, and
one study showed that the synprint loop of P/Q-type Ca2+ chan-
nels can be phosphorylated in vitro by CDK5(Tomizawa et al.,
2002). Thus it is plausible that the acceleration of exocytosis
kinetics caused by removal of CDK5 may result from enhance-
ment of Ca2+ channel function. Relatively little is currently known
about how CDK5 is regulated, other than the identity of the two
known cyclins, p35 and p39. It has been suggested that CDK5,
like CN, can be modulated by elevations in intracellular calcium,
because CDK5 has been shown to interact with calmodulin in
a calcium-dependent manner (Dhavan et al., 2002).
The close functional correspondence between neurons whose
activity has been chronically silenced with those whose CDK5
activity has been ablated, and the demonstration that presyn-
aptic CDK5 levels are suppressed during silencing, indicates
a convergence at the level of molecular pathways for these
experiments. An important direction for future studies will be to
decipher how silencing mediates loss of presynaptic CDK5.
The studies we describe here report a previously unappreci-
ated and potent control system for neurotransmitter release,
demonstrating that CDK5 normally suppresses presynaptic
function in at least two ways. This work should open up new
avenues in understanding how synaptic transmission is con-
trolled in both normal and diseased states of brain function.EXPERIMENTAL PROCEDURES
Cell Culture and Optical Setup
Hippocampal CA3-CA1 regions were dissected from 2-day-old Sprague
Dawley rats, dissociated, and plated onto poly-ornithine-coated glass for
14–21 days as previously described (Ryan, 1999). All constructs were trans-
fected 8 days after plating. Experiments were performed 14–21 days after
plating (6–13 days after transfection), and the coverslips were mounted in
a rapid-switching, laminar-flow perfusion and stimulation chamber (volume
75 ml) on the stage of a custom-built, laser-illuminated epifluorescence
microscope. Live cell images were acquired with an Andor iXon+ (Model #
DU-897E-BV) back-illuminated EM CCD camera in epifluorescence. A solid-
state, diode-pumped 488 nm or 532 nm laser (for mCherry excitation), shut-
tered using Acousto-Optic Tunable Filters (AOTF) in all non-data acquiring
periods, served as a common light source for setup. Fluorescence excitation
and collection was done through a 403 1.3 NA Fluar Zeiss objective using
515–560 nm emission and 510 nm dichroic filters (for pHluorin) and a 572–
647 nm emission filter (for mCherry). APs were evoked by passing 1ms current
pulses, yielding fields of 10 V/cm via platinum-iridium electrodes. Cells werecontinuously perfused (0.2 ml/min) in a saline solution containing (in mM)
119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 25 HEPES (buffered to pH 7.4),
30 glucose, 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and 50 mM
D,L-2-amino-5-phosphonovaleric acid (AP5). Temperature was clamped at
30C to decrease effect from temperature fluctuation. Unless otherwise noted,
all chemicals were obtained from Sigma (St. Louis, MO). NH4Cl applications
were done with 50 mM NH4Cl in substitution of 50 mM of NaCl (buffered to
pH 7.4). Advasep was obtained from CyDex (Lenexa, KS) and used at 1 mM
where indicated. Bafilomycin (Calbiochem) was used at 1 mMwhere indicated.
Roscovitine (Calbiochem) was used at 100 mMwhere indicated. TTX (Alomone
labs, Israel) was used at 1 mM.
Immunofluorescence and Quantification
To quantify the efficiency of shRNA-mediated KD, following live cell imaging,
neurons were fixed with 4% paraformaldehyde and permeabilized with 0.2%
Triton X-100, blocked with 5% BSA, and subsequently incubated with appro-
priated primary antibodies [anti-GFP (Invitrogen, CA), anti-CDK5 (Invitrogen,
CA), anti-CN B (Millipore, MA), and anti-HA (Covance)]. Alexa-488- or Alexa-
546-conjugated secondary antibodies were applied in primary antibody incu-
bated samples with different color combinations as needed. Immunofluores-
cence images of fixed cells were acquired using epifluorescence microscope
with an EMCCD camera. Expression levels of CDK5 andCNweremeasured at
cell bodies corrected for background in surrounding regions to avoid possible
spatial overlap with other cells. This was compared to the fluorescence
intensity in nontransfected (GFP-negative) cell bodies. To quantify presynaptic
CDK5 levels, neurons were cotranfectected with GFP-synapsin I and
HA-CDK5. Four days after transfection (DIV 12), neurons were treated with
or without TTX (1 mM) for 3–5 days prior to immunostaining. Cells were incu-
bated with anti-HA (Covance, CA) and anti-GFP antibodies, and subsequently
incubated with Alexa-546- and Alexa-488-conjugated secondary antibodies.
HA-CDK5 levels were determined by centering ROIs on the synapsin channel
and determining the ratio of the HA-CDK5 intensity to that of GFP-synapsin I
across many boutons. GFP-synapsin I levels were not significantly affected
by TTX treatment (not shown).
Western Blot Analysis
Hippocampal CA3-CA1 regions were dissected from 2- to 3-day-old Sprague
Dawley rats, dissociated, and plated onto poly-ornithine-coated 6-well dishes
for 15–17 days. Neurons in three wells were treated with TTX (1 mM) at
12 days in vitro (DIV) for 3–5 days and neurons in the other three wells
were not treated with TTX as controls. All experiments were performed as
parallel with same condition. Cells were lysed with l buffer containing 10 mM
Tris (pH 7.4), 1% SDS, 10 mM NaF, and 1 mM PMSF, supplemented with
protease inhibitor mixture (Complete mini; Roche, Germany). Subsequently,
concentration of lysates was quantified with Bicinchoninic acid (BCA) assay
(Thermo, IL). Similar amounts of lysate were subjected to SDS-PAGE and
subsequently transferred to PVDF membranes. Membranes were incubated
with 5% nonfat dry milk for blocking, and subsequently incubated with appro-
priated antibodies [anti-dynamin I (BD transduction, CA), anti-Amphiphysin
(gift from Dr. De Camilli), anti-synapsin I (Synaptic System, Germany), anti-
VAMP2 (calbiochem, CA), anti-Munc18 (sigma, MO), and anti-Tubulin (Santa-
cruz, CA)]. Band intensities were quantified and the ratio of [TTX+]/ [TTX] was
measured after background subtraction.
Plasmids
Synthetic oligonucleotides containing the rat cdk5 cDNA target sequences
(CCTCCGGGAGATCTACTCAAA) of CDK5 and rat calcineurin b subunit
cDNA target sequences (CTATGTGTGACATCTTGTG) of CNB regulatory
subunit for cloning in pSUPER vector were synthesized (Invitrogen, CA),
annealed, and ligated into pSUPER with BglII and HindIII enzyme site accord-
ing to manufacturer’s instruction. vG-pH-mCh was subcloned such that
mCherry was connected in frame to the C terminus of vG-pH exposed to the
cytoplasmic region. The HA-CDK5 construct resistant to shRNA CDK5 was
generated using Quick Change Site-Directed mutagenesis (Stratagene, La
Jolla, CA). The sequence for shRNA CDK5 corresponding to nucleotide posi-
tions 144–168 was mutated to CCTGCGCGAAATATGTCTACTCAAA, leavingNeuron 67, 797–809, September 9, 2010 ª2010 Elsevier Inc. 807
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CNB was utilized, which has one nucleotide mismatch.
Image and Data Analysis
Images were analyzed in ImageJ (http://rsb.info.nih.gov/ij) using a custom-
written plugin (http://rsb.info.nih.gov/ij/plugins/time-series.html). All visible
varicosities were selected for analysis by testing their responsiveness to test
application of NH4Cl. Fluorescence time course traces were analyzed using
Origin Pro (ver 7.5). The peak of amplitude at 100 AP was selected at the
end of stimulation at 10 Hz 10 s. Bafilomycin and NH4Cl were analyzed by
mean value of plateau regions. Silent boutons were defined as those where
the response of 100 APs was smaller than the standard deviation (s) of the
baseline before stimulation (DF100  s % 0). In order to measure the rate of
exocytosis, the traces in the presence of bafilomycin were fitted with a single
exponential as previously described (Kim and Ryan, 2009a).
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes seven figures and can be
found with this article online at doi:10.1016/j.neuron.2010.08.003.
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